CN1879841A - A Chinese medicine for treating leukemia - Google Patents
A Chinese medicine for treating leukemia Download PDFInfo
- Publication number
- CN1879841A CN1879841A CNA2006100127351A CN200610012735A CN1879841A CN 1879841 A CN1879841 A CN 1879841A CN A2006100127351 A CNA2006100127351 A CN A2006100127351A CN 200610012735 A CN200610012735 A CN 200610012735A CN 1879841 A CN1879841 A CN 1879841A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- root
- fructus
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Disclosed is a Chinese medicament for treating leukemia, wherein the raw materials include antelope's bone, buffalo horn, earthworm, natural indigo, isatic root, zedoary, arctium fruit, subprostrate sophora root, bulb of edible tulip, oldenlandia, ganoderma lucidum, radix rubiae, fleece-flower root, ligustrum japonicum, matrimony vine, prepared rhizome of rehmannia, kudzu vine root, notoginseng, field thistle, asparagus root, lilyturf root, Chinese angelica root, gen-seng, astragalus root, donkey-hide gelatin, coix seed, licorice root, white atractylodes rhizome, poria cocos wolf, amomum fruit, dried rehmannia root, bark of peony root.
Description
Technical field
The invention belongs to the leukemic medicine of a kind of treatment, specifically is the Chinese drugs agentia of feedstock production with the Chinese herbal medicine.
Background technology
Leukemia is called leukemia by modern medicine, it is a kind of disease that seriously jeopardizes human health, acute myeloblastic leukemia is arranged, chronic myelocytic leukemia, Lymphocytic leukemia thrombocytopenia, many types such as aplastic anemia, its cause is many by viral factor, due to the radiation factor, inherited genetic factors etc., also there is not effective Therapeutic Method at present.Present Therapeutic Method mainly is operation, radiotherapy, chemotherapy, though radiotherapy or chemotherapy can be killed the part cancerous cell, patient symptom is temporarily taken a turn for the better or alleviate, but when it kills and wounds cancerous cell, injured the normal immunocyte leukocyte, damaged the human righteousness, side effect is big, bring insufferable misery to patient, some critical patient is forced to therapy discontinued.Numerous medical personnels are at the effective ways of studying intensively, seek treatment, but also effectively do not cure leukemic medicament at present.
Summary of the invention
The purpose of this invention is to provide the leukemic Chinese medicine of a kind of treatment, screening has heat-clearing and toxic substances removing from Chinese herbal medicine, sets upright and gets rid of evils, the kidney tonifying spleen reinforcing, the natural plant of benefiting qi and nourishing blood, the effectively growth of anticancer, make patient's cancerous cell approaching, reach the purpose of healing to normal cell.
Medicine of the present invention is formed (consumption is a weight portion) by following component:
Os Caprae Saigae Tataricae 6-15 part, Cornu Bubali 5-10 part, Lumbricus 6-10 part, Indigo Naturalis 3-9 part, Radix Isatidis 10-20 part, Rhizoma Curcumae 6-10 part, the other sub-5-15 part of cattle, Radix Sophorae Tonkinensis 6-15 part, Pseudobulbus Cremastrae Seu Pleiones 3-6 part, Herba Hedyotidis Diffusae 10-30 part, Ganoderma 5-10 part, Radix Rubiae 6-10 part, Radix Polygoni Multiflori 9-15 part, Fructus Ligustri Lucidi 10-15 part, Fructus Lycii 6-15 part, Radix Rehmanniae Preparata 6-10 part, Radix Puerariae 5-10 part, Radix Notoginseng 5-10 part, Herba Cirsii 6-10 part, Radix Asparagi 10-15 part, Radix Ophiopogonis 10-15 part, Radix Angelicae Sinensis 6-15 part, Radix Ginseng 3-9 part, Radix Astragali 10-30 part, Colla Corii Asini 6-10 part, Semen Coicis 10-20 part, Radix Glycyrrhizae 3-6 part, Rhizoma Atractylodis Macrocephalae 10-15 part, Poria 6-10 part, Fructus Amomi 3-6 part, Radix Rehmanniae 10-15 part, Cortex Moutan 3-6 part.
The formula optimization weight proportion scope of preparation medicine of the present invention is:
Os Caprae Saigae Tataricae 8-12 part, Cornu Bubali 7-9 part, Lumbricus 7-8 part, Indigo Naturalis 5-7 part, Radix Isatidis 14-18 part, Rhizoma Curcumae 7-9 part, the other sub-8-12 part of cattle, Radix Sophorae Tonkinensis 8-12 part, Pseudobulbus Cremastrae Seu Pleiones 3-6 part, Herba Hedyotidis Diffusae 10-30 part, Ganoderma 5-10 part, Radix Rubiae 8-9 part, Radix Polygoni Multiflori 11-12 part, Fructus Ligustri Lucidi 13-14 part, Fructus Lycii 9-11 part, Radix Rehmanniae Preparata 7-9 part, Radix Puerariae 7-9 part, Radix Notoginseng 7-9 part, Herba Cirsii 7-9 part, Radix Asparagi 11-14 part, Radix Ophiopogonis 12-14 part, Radix Angelicae Sinensis 8-12 part, Radix Ginseng 5-7 part, Radix Astragali 15-25 part, Colla Corii Asini 7-9 part, Semen Coicis 13-17 part, Radix Glycyrrhizae 4-5 part, Rhizoma Atractylodis Macrocephalae 12-14 part, Poria 7-9 part, Fructus Amomi 4-5 part, Radix Rehmanniae 12-14 part, Cortex Moutan 4-5 part.
The optimum weight proportioning of medicine of the present invention is:
10 parts of Os Caprae Saigae Tataricaes, 8 parts of Cornu Bubalis, 9 parts of Lumbricuss, 6 parts of Indigo Naturaliss, 15 parts of Radix Isatidis, 8 parts of Rhizoma Curcumae, 10 parts of the other sons of cattle, 10 parts of Radix Sophorae Tonkinensiss, 5 parts of Pseudobulbus Cremastrae Seu Pleioness, 20 parts of Herba Hedyotidis Diffusaes, 7 parts of Ganodermas, 8 parts in Radix Rubiae, 12 parts of Radix Polygoni Multiflori, 13 parts of Fructus Ligustri Lucidi, 10 parts of Fructus Lyciis, 8 parts in Radix Rehmanniae Preparata, 8 parts of Radix Puerariaes, 7 parts of Radix Notoginseng, 8 parts of Herba Cirsiis, 12 parts of Radix Asparagis, 12 parts of Radix Ophiopogonis, 11 parts of Radix Angelicae Sinensis, 6 parts of Radix Ginsengs, 20 parts of the Radixs Astragali, 8 parts in Colla Corii Asini, 15 parts of Semen Coiciss, 5 parts in Radix Glycyrrhizae, 12 parts of the Rhizoma Atractylodis Macrocephalaes, 8 parts in Poria, 5 parts of Fructus Amomis, 13 parts in the Radix Rehmanniae, 5 parts of Cortex Moutans.
Pharmacology analysis: the present invention is at first with Cornu Bubali, Cornu Saigae Tataricae salty-cold, closing Pheretima clearly thoroughly is good at network and walks marrow, the oblique heat effect of the bright marrow of straight folding is a priming, and draw flavors such as Indigo Naturalis, Radix Isatidis, Folium Isatidis, the other son of cattle, Herba Hedyotidis Diffusae, Rhizoma Curcumae, Ganoderma, nature and flavor bitter cold, heat-clearing and toxic substances removing wherein contain indirubin, cancerous cell there is direct killing effect, simultaneously cancerous cell is transformed to normal cell.Radix Polygoni Multiflori, Fructus Lycii, Radix Asparagi, Radix Ophiopogonis can strengthen the phagocytic activity that gulps down of reticuloendothelial system cell, and the rising peripheral leukocytes improves immunity, strengthen cardiorenal function and recover.Radix Notoginseng, Radix Rubiae, Herba Cirsii, Radix Astragali clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling, hemostasis.Radix Rehmanniae Preparata, Radix Ginseng, Colla Corii Asini, Radix Angelicae Sinensis, the Radix Rehmanniae, Semen Coicis benefiting qi and nourishing blood, harmonizing the liver and spleen makes QI and blood, and lymphocyte normally moves.The Radix Puerariae expelling pathogenic factors from muscles for reducing heat is dispersed virus, and heresy goes just to deposit, and human body is normally moved.Prescription integral body has heat-clearing and toxic substances removing, direct killing cancer cell, sets upright and gets rid of evils, and recovers the effect of human body.
From the principle of pestilence theory treatment, in conjunction with pestilence defensive-qi-nutrient-blood change of disease rule, leukemia is in marrow blood battalion headquarter position, due to warm viral cancerous cell corrodes.Employing is got rid of evils and is gone out, and allows fall back on blood system by the oblique fever virus of bone marrow, and blood system moves back battalion again and divides, and is divided by battalion and moves back edema caused by disorder of QI, is moved back by edema caused by disorder of QI and defends branch, evilly disperses by going from defending branchs, and heresy is moved back body and pacified.
The specific embodiment
After medicine of the present invention makes according to set of dispense, can take by fried according to a conventional method one-tenth decoction, also can manufacture the Chinese medicine pill according to a conventional method, the Chinese medicine electuary is taken, can also daily dosage effective component extracting according to Chinese herbal medicine after, make capsule and quantitatively take on time.
Use prescription treatment leukemia 20 examples of the present invention, cure rate reaches 66%, and effective percentage reaches 90%, has 2 routine patients not good through therapeutic effect, the treatment of transferring from one hospital to another.
Model case: thank * *, the man, 27 years old, went to a doctor in November, 2004
Aplastic anemia during prescription on individual diagnosis, the face pale asphyxia, not seeing has bleeding, the systemic sustained heating.Use the fried medicament of Chinese medicine of the present invention, method according to routine is fried, and one day twice, each potion of morning and evening, further consultation after taking medicine continuously 7, sb.'s illness took a favorable turn after conscious the taking medicine, and after taking medicine again 7, resembles disappearance to the positive disease of examination in hospital, recover certain work capacity after half a year, physical recovery is normal after 1 year, does not have recurrence so far, can operate as normal.
Claims (3)
1, the leukemic Chinese medicine of a kind of treatment is characterized in that it is the medicament of being made by the following weight proportion raw material:
Os Caprae Saigae Tataricae 6-15 part, Cornu Bubali 5-10 part, Lumbricus 6-10 part, Indigo Naturalis 3-9 part, Radix Isatidis 10-20 part, Rhizoma Curcumae 6-10 part, the other sub-5-15 part of cattle, Radix Sophorae Tonkinensis 6-15 part, Pseudobulbus Cremastrae Seu Pleiones 3-6 part, Herba Hedyotidis Diffusae 10-30 part, Ganoderma 5-10 part, Radix Rubiae 6-10 part, Radix Polygoni Multiflori 9-15 part, Fructus Ligustri Lucidi 10-15 part, Fructus Lycii 6-15 part, Radix Rehmanniae Preparata 6-10 part, Radix Puerariae 5-10 part, Radix Notoginseng 5-10 part, Herba Cirsii 6-10 part, Radix Asparagi 10-15 part, Radix Ophiopogonis 10-15 part, Radix Angelicae Sinensis 6-15 part, Radix Ginseng 3-9 part, Radix Astragali 10-30 part, Colla Corii Asini 6-10 part, Semen Coicis 10-20 part, Radix Glycyrrhizae 3-6 part, Rhizoma Atractylodis Macrocephalae 10-15 part, Poria 6-10 part, Fructus Amomi 3-6 part, Radix Rehmanniae 10-15 part, Cortex Moutan 3-6 part.
2, the leukemic Chinese medicine of a kind of treatment is characterized in that wherein the weight proportion of each raw material is:
Os Caprae Saigae Tataricae 8-12 part, Cornu Bubali 7-9 part, Lumbricus 7-8 part, Indigo Naturalis 5-7 part, Radix Isatidis 14-18 part, Rhizoma Curcumae 7-9 part, the other sub-8-12 part of cattle, Radix Sophorae Tonkinensis 8-12 part, Pseudobulbus Cremastrae Seu Pleiones 3-6 part, Herba Hedyotidis Diffusae 10-30 part, Ganoderma 5-10 part, Radix Rubiae 8-9 part, Radix Polygoni Multiflori 11-12 part, Fructus Ligustri Lucidi 13-14 part, Fructus Lycii 9-1 part, Radix Rehmanniae Preparata 7-9 part, Radix Puerariae 7-9 part, Radix Notoginseng 7-9 part, Herba Cirsii 7-9 part, Radix Asparagi 11-14 part, Radix Ophiopogonis 12-14 part, Radix Angelicae Sinensis 8-12 part, Radix Ginseng 5-7 part, Radix Astragali 15-25 part, Colla Corii Asini 7-9 part, Semen Coicis 13-17 part, Radix Glycyrrhizae 4-5 part, Rhizoma Atractylodis Macrocephalae 12-14 part, Poria 7-9 part, Fructus Amomi 4-5 part, Radix Rehmanniae 12-14 part, Cortex Moutan 4-5 part.
3, the leukemic Chinese medicine of a kind of treatment is characterized in that wherein the weight proportion of each raw material is:
10 parts of Os Caprae Saigae Tataricaes, 8 parts of Cornu Bubalis, 9 parts of Lumbricuss, 6 parts of Indigo Naturaliss, 15 parts of Radix Isatidis, 8 parts of Rhizoma Curcumae, 10 parts of the other sons of cattle, 10 parts of Radix Sophorae Tonkinensiss, 5 parts of Pseudobulbus Cremastrae Seu Pleioness, 20 parts of Herba Hedyotidis Diffusaes, 7 parts of Ganodermas, 8 parts in Radix Rubiae, 12 parts of Radix Polygoni Multiflori, 13 parts of Fructus Ligustri Lucidi, 10 parts of Fructus Lyciis, 8 parts in Radix Rehmanniae Preparata, 8 parts of Radix Puerariaes, 7 parts of Radix Notoginseng, 8 parts of Herba Cirsiis, 12 parts of Radix Asparagis, 12 parts of Radix Ophiopogonis, 11 parts of Radix Angelicae Sinensis, 6 parts of Radix Ginsengs, 20 parts of the Radixs Astragali, 8 parts in Colla Corii Asini, 15 parts of Semen Coiciss, 5 parts in Radix Glycyrrhizae, 12 parts of the Rhizoma Atractylodis Macrocephalaes, 8 parts in Poria, 5 parts of Fructus Amomis, 13 parts in the Radix Rehmanniae, 5 parts of Cortex Moutans.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100127351A CN100421717C (en) | 2006-05-17 | 2006-05-17 | A Chinese medicine for treating leukemia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100127351A CN100421717C (en) | 2006-05-17 | 2006-05-17 | A Chinese medicine for treating leukemia |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1879841A true CN1879841A (en) | 2006-12-20 |
CN100421717C CN100421717C (en) | 2008-10-01 |
Family
ID=37518342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100127351A Expired - Fee Related CN100421717C (en) | 2006-05-17 | 2006-05-17 | A Chinese medicine for treating leukemia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100421717C (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101181516B (en) * | 2007-11-15 | 2011-03-16 | 张春秀 | Chinese medicine prescription orally taken for curing leukaemia |
CN102048977A (en) * | 2011-01-12 | 2011-05-11 | 徐祖书 | Chinese medicinal composition for treating chronic myeloid leukemia |
CN102078542A (en) * | 2011-01-12 | 2011-06-01 | 徐祖书 | Traditional Chinese medicine combination for treating acute granulocyte AML-M4 leukemia |
CN102600362A (en) * | 2012-02-02 | 2012-07-25 | 焦成玉 | Traditional Chinese medicine oral liquid for treating leukemia and preparation method thereof |
CN102772685A (en) * | 2012-07-16 | 2012-11-14 | 梁艳龙 | Traditional Chinese medicinal preparation for treating aplastic anemia |
CN103736038A (en) * | 2014-02-19 | 2014-04-23 | 段寒 | Chinese medicine combination for curing leukemia, preparation and application thereof |
CN105663419A (en) * | 2016-03-25 | 2016-06-15 | 杨忠雅 | Formula for pure traditional Chinese medicines capable of generating new blood, dispelling extravasated blood and treating leukemia |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1216620C (en) * | 2002-08-06 | 2005-08-31 | 王凯 | Composite medicine for treating leukemia |
-
2006
- 2006-05-17 CN CNB2006100127351A patent/CN100421717C/en not_active Expired - Fee Related
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101181516B (en) * | 2007-11-15 | 2011-03-16 | 张春秀 | Chinese medicine prescription orally taken for curing leukaemia |
CN102048977A (en) * | 2011-01-12 | 2011-05-11 | 徐祖书 | Chinese medicinal composition for treating chronic myeloid leukemia |
CN102078542A (en) * | 2011-01-12 | 2011-06-01 | 徐祖书 | Traditional Chinese medicine combination for treating acute granulocyte AML-M4 leukemia |
CN102078542B (en) * | 2011-01-12 | 2012-05-30 | 徐祖书 | Traditional Chinese medicine combination for treating acute granulocyte AML-M4 leukemia |
CN102600362A (en) * | 2012-02-02 | 2012-07-25 | 焦成玉 | Traditional Chinese medicine oral liquid for treating leukemia and preparation method thereof |
CN102600362B (en) * | 2012-02-02 | 2014-01-08 | 焦成玉 | Traditional Chinese medicine oral liquid for treating leukemia and preparation method thereof |
CN102772685A (en) * | 2012-07-16 | 2012-11-14 | 梁艳龙 | Traditional Chinese medicinal preparation for treating aplastic anemia |
CN102772685B (en) * | 2012-07-16 | 2014-07-02 | 梁艳龙 | Traditional Chinese medicinal preparation for treating aplastic anemia |
CN103736038A (en) * | 2014-02-19 | 2014-04-23 | 段寒 | Chinese medicine combination for curing leukemia, preparation and application thereof |
CN103736038B (en) * | 2014-02-19 | 2016-01-20 | 段寒 | Treat leukemic Chinese medicine composition, its preparation and application |
CN105663419A (en) * | 2016-03-25 | 2016-06-15 | 杨忠雅 | Formula for pure traditional Chinese medicines capable of generating new blood, dispelling extravasated blood and treating leukemia |
Also Published As
Publication number | Publication date |
---|---|
CN100421717C (en) | 2008-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1124153C (en) | Medicinal composition for restoring cardiac collaterals and its application | |
CN1330347C (en) | Gongbu ointment | |
CN100421717C (en) | A Chinese medicine for treating leukemia | |
CN1651064A (en) | Medicinal composition for treating tumour and its preparation method | |
CN1840126A (en) | Chinese medicine for treating amblyopia and myopia | |
CN102614442B (en) | Traditional Chinese drug capsules with effects of immunity enhancing, blood reinforcing and antiemesis | |
CN1150018C (en) | Medicine for treating tachy-arrhythmia | |
CN104225166A (en) | Chinese medicine composition for treating amenorrhea and preparation method thereof | |
CN1049827C (en) | Anti-cancer powder | |
CN1134824A (en) | Oral liquid for regulating women's sexual function | |
CN101623352A (en) | Medicine for treating acne and preparation method thereof | |
CN1082376C (en) | Pathogenic factor eliminating and healthy energy supporting anticancer medicine | |
CN1260983A (en) | Process for preparing leukemia medicines | |
CN1077896A (en) | Medicine for psoriasis and manufacture method | |
CN1127344C (en) | Oral pill for curing diabetes and its complication | |
CN101745080A (en) | Chinese patent medicine for treating leukemia | |
CN101199761B (en) | Drug for treating arteriosclerosis | |
CN1052914C (en) | Suyuwan pill for curing leucoderma | |
CN101314010A (en) | Liquefied clearing pill | |
CN1293908C (en) | Cancer preventing and curing Chinese medicine of two snakes and Ganoderma Lucidum seu Japonicum | |
CN1219540C (en) | Chinese medicine for treating leukoderma and the prepn process of the tablets | |
CN1151813C (en) | Traditional Chinese medicine composition for curing insomnia | |
CN1062172C (en) | Medicine for treating cervical spondylopathy | |
CN1113804A (en) | Antianemic powder and its preparing method | |
CN1124155C (en) | Medicine for treating leukoderma and preparing process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20081001 Termination date: 20140517 |